November 20, 2012 / 7:20 PM / 5 years ago

FDA approves HeartWare's implantable heart pump

Nov 20 (Reuters) - The U.S. Food and Drug Administration said it has approved HeartWare International Inc’s heart pump that supports blood flow in people with failing hearts who are awaiting a transplant.

HeartWare’s left ventricular assist device is designed to be implanted in the chest near the heart and used inside or outside the hospital.

FDA said the life-saving benefits of the device in the intended population of patients with end-stage heart failure outweighed risks observed during the clinical trial, such as infection and stroke.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below